Axe Compute Inc.
NCM: AGPULive Quote
📈 ZcoreAI Score
Our AI model analyzes Axe Compute Inc.'s price action across multiple timeframes using regression channels and statistical scoring.
Get AGPU Z-Score →About Axe Compute Inc.
Technology
Software - Infrastructure
Axe Compute Inc., a knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of cancer therapies. It operates through two segments, Pittsburgh and Eagan. The Pittsburgh segment provides services that include the application of AI using its proprietary biobank of 150,000+ tumor samples. This segment also creates proprietary 3D culture models used in drug development. Its Eagan segment produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. Predictive Oncology Inc. has a strategic collaboration with Every Cure to identify and prioritize drugs for repurposing. The company was formerly known as Predictive Oncology Inc. and changed its name to Axe Compute Inc. in December 2025. Axe Compute Inc. was incorporated in 2002 and is headquartered in Pittsburgh, Pennsylvania.
📊 Fundamental Analysis
Axe Compute Inc. demonstrates a profit margin of 0.0%, which is below the sector average, suggesting competitive pressure.
The company recently reported -1.3% revenue growth, which is negative, indicating a recent decline in revenue.
Return on Equity (ROE) is -980.1%, which indicates that capital utilization is currently under pressure.
At a current price of $3.98, AGPU currently trades near the bottom of its 52-week range (9%), indicating potential value or weakness (Range: $1.03 - $32.10).
🏥 Financial Health
🔴
Profit Margin
Weak
🔴
Debt/Equity
Elevated
🔴
Revenue Growth
Weak
🔴
Return on Equity
Weak
🔴
Beta (Risk)
High Volatility
Key Financials
Market Cap
$22.05M
Trailing P/E
--
Forward P/E
--
Beta (5Y)
1.44
52W High
$32.10
52W Low
$1.03
Avg Volume
2.01M
Day High
Day Low